Medications/Drugs News Headlines

(Reuters) - Two more people have died from fungal meningitis linked to steroid injections, bringing the total to 14 deaths since the outbreak began last month, the U.S. Centers for Disease Control said on Thursday. A total of 170 people have been stricken with a rare fungal meningitis in 11 states since the outbreak began, …

Three drugs that were originally developed to treat late-stage Alzheimer's disease are being given a second look after early research suggested that they may have more success in preventing the disease to begin with. A large clinical trial to test the efficacy of the drugs in preventing Alzheimer's in people who have the …

NEW YORK (Reuters) - In Dendreon Corp's most important clinical trial for the controversial cancer therapy Provenge, researchers analyzed some of the data differently from how the company told U.S. regulators they would, according to documents reviewed by Reuters. That not only was a departure from scientific norms, but …

The specialty pharmacy linked to a deadly meningitis outbreak may have misled regulators and done work beyond the scope of its state license, Massachusetts Gov. Deval Patrick said Wednesday.

ZURICH (Reuters) - Leading drugmakers will help set up psychological centers for victims of child sex abuse in an effort to counter the long-term health problems suffered by victims. Roche, Merck and GlaxoSmithKline are to join forces with Harvard Medical School, the Mayo Clinic and others to improve medical education and …

LONDON (Reuters) - GlaxoSmithKline, criticized in the past for keeping important information about its medicines to itself, is to lift the lid on more of its drug data secrets. Three months after GSK was fined $3 billion for fraud in the United States, where prosecutors accused it of concealing safety issues, chief executive …

NASHVILLE, Tennessee (Reuters) - The deadly meningitis outbreak that has claimed a dozen lives is prompting calls for increased oversight of the nation's custom-made pharmaceutical industry, amid charges that the company at the center of the scare may have misled U.S. regulators. On Wednesday, Idaho became the 11th state …

BOSTON (Reuters) - A Massachusetts specialist pharmacy linked to a company at the center of a major health scare closed temporarily on Wednesday and a state regulator clamped down on such operations in the wake of a meningitis outbreak that has claimed a dozen lives. The Massachusetts Department of Public Health said Ameridose …

According to the Alzheimer’s Association, an estimated 5.4 million Americans are living with Alzheimer’s disease. And the number of people with the disease will increase each year as the proportion of the U.S. population over age 65 continues to grow—and it’s predicated it will escalate rapidly as the baby boom generation …

BOSTON (Reuters) - A Massachusetts company that mixes drugs for hospitals on Wednesday gave up an attempt to distance itself from an affiliated pharmacy linked to a deadly U.S. outbreak of fungal meningitis. Ameridose LLC agreed to close down for 12 days while state and federal officials investigate the New England Compounding …

BOSTON (Reuters) - The campaign of U.S. Senator Scott Brown said on Wednesday it would donate to charity the campaign contributions received from the owners of a pharmacy at the center of a deadly meningitis outbreak. "Sen. Brown supports a full and thorough investigation to determine responsibility for this tragedy and …

BOSTON (Reuters) - Two Boston-area pharmacy companies that share common ownership with the company at the center of a deadly U.S. meningitis outbreak plan to cease operations temporarily as a precautionary move, Massachusetts health officials said on Wednesday. Ameridose LLC, a private company that mixes drugs for hospitals …

The specialty pharmacy linked to a deadly meningitis outbreak may have misled regulators and done work beyond the scope of its state license, Massachusetts Gov. Deval Patrick said Wednesday.

(Reuters) - After a nationwide meningitis outbreak was tied to drugs shipped from a plant in Massachusetts, the state is requiring all pharmacy compounders to sign a statement saying they are complying with regulations on their work, officials said on Wednesday. The Massachusetts Department of Public Health also confirmed …

NEW YORK (Reuters Health) - New drug treatments have dramatically improved survival for people infected with HIV, but a new study finds that African Americans and less educated Americans have not seen the same gains as others, suggesting differences in access to available treatments. "There have been substantial declines …

NEW YORK (Reuters Health) - Nearly a quarter of the new drugs approved in Canada eventually get a serious safety warning, or have to be pulled from the market for safety reasons, according to a new study. And for medications that get the fast-track "priority review" by the country's health regulator, the chance that a serious …

WASHINGTON (Reuters) - The Obama administration on Wednesday urged Congress to give the Food and Drug Administration greater authority to regulate compounded drugs of the kind linked to a deadly meningitis outbreak spanning 10 U.S. states. "This outbreak began at a compounding pharmacy and the FDA has very limited authority …

(Reuters) - Eighteen more people have contracted meningitis from potentially tainted steroid injections, and a death was officially confirmed in Florida, bringing the total number killed to 12, the Centers for Disease Control said on Wednesday. A total of 137 people have been stricken with a rare fungal meningitis in 10 …

BOSTON (Reuters) - Ameridose LLC, a private company that mixes drugs for hospitals nationwide, sought on Wednesday to distance itself from the firm at the center of a deadly U.S. outbreak of fungal meningitis, even though the two pharmacies have common owners. ...

CHICAGO/LONDON (Reuters) - For some scientists, winning a Nobel Prize marks the end of a long and successful career. But the work, in a sense, is just beginning for newly minted Nobel laureates in chemistry Dr. Brian Kobilka, 57, of Stanford University in California, and his mentor, Dr. Robert Lefkowitz, 69, of Duke University …

NEW YORK (Reuters Health) - Strokes are most common in old age, but new research suggests that lifestyle is putting young people increasingly at risk for stroke too. In a study of two U.S. states, researchers found the rate of strokes among adults younger than 55 nearly doubled between 1993 and 2005. Among whites ages 20 …

NEW YORK (Reuters) - Experimental Alzheimer's drugs from Roche Holding AG and Eli Lilly & Co have been selected for a high-profile clinical trial to test whether it is possible to prevent the brain-wasting disease from developing in at-risk patients. The trial, expected to start early next year, will enroll 160 patients …

STOCKHOLM (Reuters) - Two American scientists won the 2012 Nobel Prize for chemistry on Wednesday for research into how cells respond to external stimuli that is helping to develop better drugs to fight diseases such as diabetes, cancer and depression. The Royal Swedish Academy of Sciences said the 8 million crown ($1.2 …